Mia Hashibe

Mia Hashibe, PhD, received her Bachelor of Science degree in Biology/Japanese at UCLA and her MPH and PhD in Epidemiology degrees from the UCLA School of Public Health. After obtaining her PhD, she held a postdoctoral fellow and scientist position at the International Agency for Research on Cancer in Lyon, France. She is currently an Adjunct Professor in the Department of Epidemiology at the UCLA Fielding School of Public Health and a Professor in the Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine and a Huntsman Cancer Institute investigator. 

Dr. Hashibe’s research interests are on cancer survivorship, health disparities and molecular cancer epidemiology. She has led projects within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium on the lifestyle and genetic factors of head and neck cancer. She also completed a head and neck cancer case-control study in East Asia, and a head and neck and lung cancer case-control study in Nepal. Her current NCI funded grants include a rural cancer survivors cohort, identifying cancer recurrences with novel data linkages, and a junior faculty training grant on leadership, mentorship and health disparities in cancer research.

 

Education

  • PhD, Epidemiology, University of Los Angeles, Los Angeles, CA
  • MPH, Epidemiology, University of Los Angeles, Los Angeles, CA
  • BS, Biology, University of Los Angeles, Los Angeles, CA

Related Tags

Areas of Interest

Dr. Hashibe’s research interests are on cancer survivorship, health disparities and molecular cancer epidemiology. She has led projects within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium on the lifestyle and genetic factors of head and neck cancer. She also completed a head and neck cancer case-control study in East Asia, and a head and neck and lung cancer case-control study in Nepal. Her current NCI funded grants include a rural cancer survivors project, identifying cancer recurrences with novel data linkages, and a junior faculty training grant on leadership, mentorship and health disparities in cancer research.

Selected Publications

 

1.         Anzai Y, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Galvao C, Monroe M, Hashibe M. Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study. Radiology. 2023;307(2):e212915. PubMed PMID: 36625743; PMCID: PMC10102644.

2.         Chang CP, Ho TF, Snyder J, Dodson M, Deshmukh V, Newman M, Date A, Henry NL, Hashibe M. Breast cancer survivorship and sexual dysfunction: a population-based cohort study. Breast Cancer Res Treat. 2023;200(1):103-13. PubMed PMID: 37160510; PMCID: PMC10382144.

3.         Hu S, Baraghoshi D, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Peoples AR, Gaffney D, Hashibe M. Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer Med. 2023;12(2):1801-12. PubMed PMID: 35773781; PMCID: PMC9883396.

4.         Huang D, Chang CE, Newman M, Deshmukh V, Snyder J, Date A, Galvao C, Lloyd S, Henry NL, O'Neil B, Hashibe M. Adverse health outcomes among rural prostate cancer survivors: A population-based study. Cancer Epidemiol. 2023;86:102430. PubMed PMID: 37473579.

5.         Koric A, Mark B, Chang CP, Lloyd S, Dodson M, Deshmukh VG, Newman M, Date A, Gren LH, Porucznik CA, Haaland B, Henry NL, Hashibe M. Adverse Health Outcomes Among Rural And Urban Breast Cancer Survivors: A Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. 2023. PubMed PMID: 37462723.

6.         Nielsen S, O'Neil B, Chang CP, Mark B, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Henry NL, Lloyd S, Hashibe M. Determining the association of rurality and cardiovascular disease among prostate cancer survivors. Urol Oncol. 2023. PubMed PMID: 37455231.

7.         Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Porucznik C, Shoaf K, Stanford J, Lee C, Hashibe M. Contributions of cancer treatment, comorbidities, and obesity to aging-related disease risks among non-Hodgkin lymphoma survivors. Cancer Causes Control. 2023;34(2):171-80. PubMed PMID: 36414860.

8.         Zhang M, Hashibe M, Rao JY, Jung SY, Tashkin DP, Morgenstern H, Zhang ZF. Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County. Am J Drug Alcohol Abuse. 2023:1-10. PubMed PMID: 37433108.

9.         Chang CP, Wilson CM, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Stanford JB, Gaffney D, Mooney K, Hashibe M. Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study. Support Care Cancer. 2022;31(1):51. PubMed PMID: 36526929; PMCID: PMC9850804.

10.       Koric A, Chang CP, Mark B, Rowe K, Snyder J, Dodson M, Deshmukh VG, Newman MG, Fraser AM, Smith KR, Date AP, Gren LH, Porucznik CA, Haaland BA, Henry NL, Hashibe M. Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort study. Cancer. 2022;128(14):2826-35. PubMed PMID: 35561317; PMCID: PMC9991862.

11.       Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe M. Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer. 2022;128(19):3564-72.PubMed PMID: 35916651.

12.       Cohn AM, Blount BC, Hashibe M. Nonmedical Cannabis Use: Patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk. J Natl Cancer Inst Monogr. 2021;2021(58):53-67. PubMed PMID: 34850898; PMCID: PMC8634557.

13.       Hu Q, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Gren LH, Porucznik C, Stanford JB, Gaffney D, Henry NL, Lopez I, Hashibe M. Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort. JNCI Cancer Spectr. 2021;5(2). PubMed PMID: 33889806; PMCID: PMC8052955.

14.       Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh VG, Newman M, Fraser A, Smith KR, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe M. Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin's Lymphoma Survivors. Cancer Epidemiol Biomarkers Prev. 2021;30(12):2268-77. PubMed PMID: 34732401; PMCID: PMC9894530.

15.       Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe M. Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors. Cancer Med. 2021;10(12):4117-26. PubMed PMID: 33979029; PMCID: PMC8209610.

16.       Ose DJ, Viskochil R, Holowatyj AN, Larson M, Wilson D, Dunson WA, Deshmukh VG, Butcher JR, Taylor BR, Svoboda K, Leiser J, Tingey B, Haaland B, Wetter DW, Fisher SJ, Hashibe M, Ulrich CM. Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study. J Natl Compr Canc Netw. 2021;19(6):709-18. PubMed PMID: 34129522; PMCID: PMC8691450.

17.       Aylward A, Park J, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Rowe K, Snyder J, Deshmukh V, Newman M, Wan Y, Fraser A, Smith K, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM. Individualized prediction of late-onset dysphagia in head and neck cancer survivors. Head Neck. 2020;42(4):708-18. PubMed PMID: 32031294.

18.       Chang CP, Chen Y, Blackburn B, Abdelaziz S, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Stanford JB, Porucznik CA, Ose J, Fraser A, Smith K, Doherty J, Gaffney D, Hashibe M. Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study. Gynecol Oncol. 2020;157(2):529-35. PubMed PMID: 32122688; PMCID: PMC7869723.

19.       Hawkins ML, Blackburn BE, Rowe K, Snyder J, Deshmukh VG, Newman M, Fraser A, Smith K, Herget K, Ganz PA, Samadder NJ, Hashibe M. Endocrine and Metabolic Diseases Among Colorectal Cancer Survivors in a Population-Based Cohort. J Natl Cancer Inst. 2020;112(1):78-86. PubMed PMID: 30918958; PMCID: PMC7489083.

20.       Kawakita D, Abdelaziz S, Chen Y, Rowe K, Snyder J, Fraser A, Smith K, Herget K, Deshmukh V, Newman M, Monroe M, Hashibe M. Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study. Cancer. 2020;126(4):879-85. PubMed PMID: 31721181; PMCID: PMC6992515.

21.       Kim S, Park J, Chen Y, Rowe K, Snyder J, Fraser A, Smith K, Deshmukh VG, Newman M, Herget K, Porucznik CA, Ose D, Playdon M, Gaffney D, Hashibe M. Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. Gynecol Oncol. 2020;156(1):185-93. PubMed PMID: 31839336; PMCID: PMC7083523.

22.       Lee YA, Al-Temimi M, Ying J, Muscat J, Olshan AF, Zevallos JP, Winn DM, Li G, Sturgis EM, Morgenstern H, Zhang ZF, Smith E, Kelsey K, McClean M, Vaughan TL, Lazarus P, Chen C, Schwartz SM, Gillison M, Schantz S, Yu GP, D'Souza G, Gross N, Monroe M, Kim J, Boffetta P, Hashibe M. Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE Consortium. Am J Epidemiol. 2020;189(4):330-42. PubMed PMID: 31781743; PMCID: PMC7274188.

23.       Aylward A, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM. Rates of Dysphagia-Related Diagnoses in Long-Term Survivors of Head and Neck Cancers. Otolaryngol Head Neck Surg. 2019;161(4):643-51. PubMed PMID: 31184260; PMCID: PMC6773495.

24.       Blackburn BE, Soisson S, Rowe K, Snyder J, Fraser A, Deshmukh V, Newman M, Smith K, Herget K, Kirchhoff AC, Kepka D, Werner TL, Gaffney D, Mooney K, Hashibe M. Prognostic factors for rural endometrial cancer patients in a population-based cohort. BMC Public Health. 2019;19(1):921. PubMed PMID: 31291920; PMCID: PMC6617574.

25.       Hawkins ML, Blackburn BE, Rowe K, Snyder J, Deshmukh VG, Newman M, Fraser A, Smith K, Herget K, Ganz PA, Samadder NJ, Hashibe M. Endocrine and Metabolic Diseases among Colorectal Cancer Survivors in a Population-Based Cohort. J Natl Cancer Inst. 2019. PubMed PMID: 30918958.

26.       Lloyd S, Baraghoshi D, Tao R, Garrido-Laguna I, Gilcrease GW, 3rd, Whisenant J, Weis JR, Scaife C, Pickron TB, Huang LC, Monroe MM, Abdelaziz S, Fraser AM, Smith KR, Deshmukh V, Newman M, Rowe KG, Snyder J, Samadder NJ, Hashibe M. Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival. Am J Clin Oncol. 2019;42(4):355-62. PubMed PMID: 30844850.

27.       Blackburn BE, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Kim J, Kirchhoff AC, Porucznik C, Hanson H, Abraham D, Monroe M, Hashibe M. Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv. 2018;12(5):702-11. PubMed PMID: 30128858; PMCID: PMC6158013.

28.       Hashibe M KA, Kepka D, Kim J, Millar M, Sweeney C, Herget K, Monroe M, Henry NL, Lopez AM, Mooney K. Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah. Cancer Med. 2018;7(4):1490-7. PubMed PMID: 29533005; PMCID: PMC5911626.

29.       Park J BB, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Kirchhoff AC, Abraham D, Kim J, Monroe M, Hashibe M. Risk Factors for Cardiovascular Disease among Thyroid Cancer Survivors: Findings from the Utah Cancer Survivors Study. J Clin Endocrinol Metab. 2018. PubMed PMID: 29850817.

30.       Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe M. Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol. 2018;28(6):377-84. PubMed PMID: 29705053.

31.       Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Al-Sarray A, Werner TL, Setiawan VW, Hashibe M. Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study. J Natl Cancer Inst. 2018;110(12):1342-51. Epub 2018/05/10. doi: 10.1093/jnci/djy070. PubMed PMID: 29741696; PMCID: PMC6292788.

32.       Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Werner TL, Setiawan VW, Hashibe M. Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol. 2018;148(3):499-506. PubMed PMID: 29289418; PMCID: PMC5905702.

33.       Blackburn BE, Ganz PA, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Kim J, Kirchhoff AC, Porucznik C, Hanson H, Monroe M, Hashibe M. Aging-Related Disease Risks among Young Thyroid Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2017;26(12):1695-704. PubMed PMID: 29167277; PMCID: PMC5903447.